Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.77 |
| ▸ | USP2 | O75604 | 5/20 | 0.74 |
| ▸ | ATM | Q13315 | 2/20 | 0.74 |
| ▸ | CFTR | P13569 | 1/20 | 0.74 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.74 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | GNG2 | P59768 | 1/20 | 0.42 |
| ▸ | GNB1 | P62873 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5606345 | 0.99 | USP2 (0.76) | ABCB1USP2ATMCFTRPAX8 | |
| Hydrochloric Acid SCHEMBL29376502 | 0.99 | USP2 (0.76) | ABCB1USP2ATMCFTRPAX8 | |
| Sulfuric Acid SCHEMBL16593429 | 0.96 | ABCB1 (0.71) | ABCB1USP2ATMCFTRPAX8 | |
| Sulfuric Acid SCHEMBL16593427 | 0.93 | ABCB1 (0.68) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL23309754 | 0.90 | ABCB1 (0.76) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL9979456 | 0.90 | ABCB1 (0.79) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL14693687 | 0.90 | ABCB1 (0.76) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL29483446 | 0.88 | ABCB1 (0.63) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL14627720 | 0.88 | ABCB1 (0.63) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL3430200 | 0.87 | USP2 (0.74) | ABCB1USP2ATMCFTRPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 502 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010045529-A1 | Double-resonance-absorption microscope | OLYMPUS CORPORATION (JP) | 2001-11-29 | — | — | US | claimed |
| EP-4714951-A1 | FLUORESCENT DYE, SYNTHESIS THEREFOR AND USE THEREOF | MGI Tech Co., Ltd. (CN) | 2026-03-25 | — | — | EP | disclosed |
| US-12379375-B2 | Methods for assessing cell surface glycosylation | JUNO THERAPEUTICS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2024240051-A1 | FLUORESCENT DYE, SYNTHESIS THEREFOR AND USE THEREOF | 深圳华大智造科技股份有限公司 | 2024-11-28 | — | — | WO | disclosed |
| US-20240159743-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| WO-2023219136-A1 | FLUORESCENT PROBE FOR DETECTING PEPTIDE-LINKED HYDROLASE | 国立大学法人 東京大学 | 2023-11-16 | — | — | WO | disclosed |
| US-11796534-B2 | Methods for assessing cell surface glycosylation | JUNO THERAPEUTICS, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2023-09-12 | — | — | US | disclosed |
| WO-2023125530-A1 | ANTIBODY DRUG CONJUGATES | BEIGENE, LTD. (KY) | 2023-07-06 | — | — | WO | disclosed |
| US-20060088507-A1 | Rhodamine derivatives for photodynamic diagnosis and treatment | UNIVERSITE DE MONTREAL (CA) | 2006-04-27 | — | — | US | disclosed |
| US-6844963-B2 | Double-resonance-absorption microscope | OLYMPUS OPTICAL CO., LTD. (JP) | 2005-01-18 | — | — | US | disclosed |
| US-6667830-B1 | Super-resolution microscope system and method for illumination | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-12-23 | — | — | US | disclosed |
| EP-1267931-A1 | RHODAMINE DERIVATIVES FOR PHOTODYNAMIC DIAGNOSIS AND TREATMENT | UNIVERSITE DE MONTREAL (CA) | 2003-01-02 | — | — | EP | disclosed |
| EP-1228152-A1 | METHOD FOR PRODUCING A WOOD COATING AGENT | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-08-07 | — | — | EP | disclosed |
| US-20010045529-A1 | Double-resonance-absorption microscope | OLYMPUS CORPORATION (JP) | 2001-11-29 | — | — | US | disclosed |
| WO-2001024824-A1 | RHODAMINE DERIVATIVES FOR PHOTODYNAMIC DIAGNOSIS AND TREATMENT | UNIVERSITE DE MONTREAL (CA) | 2001-04-12 | — | — | WO | disclosed |
| WO-2001018131-A1 | METHOD FOR PRODUCING A WOOD COATING AGENT | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2001-03-15 | — | — | WO | disclosed |
| WO-1990015441-A1 | LASER DYE LIQUIDS, LASER DYE INSTRUMENTS AND METHODS | EXCITON INCORPORATED (US) | 1990-12-13 | — | — | WO | disclosed |
| US-4896329-A | Laser dye liquids, laser dye instruments and methods | EXCITON INCORPORATED (US) | 1990-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | ABCB1 2383/4885USP2 2521/4885ATM 2889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.